eCFR Reference Browser

---

title: "21 CFR §14.5"

source: "https://www.ecfr.gov/current/title-21/section-14.5"

title_number: "21"

volume_number: "1"

chapter_number: "Unknown"

subchapter_code: "A"

subchapter_subject: "GENERAL"

part_code: "14"

part_subject: "PUBLIC HEARING BEFORE A PUBLIC ADVISORY COMMITTEE"

subpart_code: "A"

subpart_subject: "General Provisions"

section_number: "14.5"

section_subject: "Purpose of proceedings before an advisory committee."

cfr_reference: "21 CFR 14.5"

title_name: "Title 21"

title_subject: "Food and Drugs"

parts_covered: "Parts 1 to 99"

revised_date: "Revised as of April 1, 2019"

publication_date: "As of April 1, 2019"

contains_description: "Containing a codification of documents of general applicability and future effect"

publication_info: "Published by the Office of the Federal Register National Archives and Records Administration as a Special Edition of the Federal Register"

---

(a)An advisory committee is utilized to conduct public hearings on matters of importance that come before FDA, to review the issues involved, and to provide advice and recommendations to the Commissioner.

(b)The Commissioner has sole discretion concerning action to be taken and policy to be expressed on any matter considered by an advisory committee.

§14.5 - Purpose of proceedings before an advisory committee.